Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

HYON AS – Company update

(Oslo, 31 January 2022) HYON AS (HYON) held a digital company update on Teams on Friday 2 February 2023 at 08:00 CET. Please see presentation enclosed which also has been distributed on the company's webpage under Investor Relations. For further information, please contact: Jørn Kristian Lindtvedt, CEO, +47 95270739   About Hyon | https://hyon.energy/ HYON delivers high-capacity hydrogen fueling systems for ships. We enable hydrogen to be transferred from shore to ships in a fast and safe manner. HYON was founded in 2017, is headquartered in Drammen, Norway and is backed

Flowscape gets breakthrough order at prestigious American hospital

One of America's leading hospitals and research institutes in cancer treatment chooses Flowscape to analyze their workplace and office utalization . For Flowscape, this is an important breakthrough into the American health care sector. The order value in the first year is USD 42,600 (SEK 440,000) and thereafter USD 15,800 (SEK 160,000) annually recurring."Although Flowscape has customers in the health care sector in other countries, this is our first major health care customer in the United States. The health care sector has more

MJR Power and Automation Successfully Delivers Power Van Project to Osbit

One of the UK’s leading marine power and electrical engineering specialists has successfully supported a major offshore equipment supplier with the delivery of a power van for a state-of-the-art subsea trenching vehicle.MJR Power and Automation has designed and constructed the 1200kW offshore power van for an innovative subsea trencher developed by offshore equipment supplier Osbit.   The vehicle, named Swordfish, is a new addition to vessel operator Jan De Nul Group’s existing fleet of trenching vehicles. Tailored to the operator’s specifications and powered by two 300kW hydraulic

Volvo Cars reports global sales of 48,520 cars in January

Volvo Cars reports sales of 48,520 in January, up 2 per cent compared to the same month last year.   Sales of Volvo Cars´Recharge models of fully electric and plug-in hybrid cars increased by 31 per cent in January year-on-year, accounting for 40.7 per cent of all Volvo cars sold globally during the month. The share of fully electric cars stood at 16.2 percent.    European sales for January reached 21,436 cars, up 14.7 per cent compared with the same period last year. The increase was led by markets such as the UK, Italy and Belgium. Recharge sales, which in addition to fully

Invitation to a Press Conference on Bittium Corporation’s Financial Statement Bulletin 2022

Bittium Corporation Press Release Invitation to a Press Conference on Bittium Corporation’s Financial Statement Bulletin 2022 Bittium Corporation’s Press Release on February 3, 2023, at 10.00 am (CET+1) Bittium Corporation’s Financial Statement Bulletin 2022 will be published on Friday, February 10, 2023, at 8.00 am (CET+1). The release will be available on company’s website www.bittium.com immediately after the publication. Bittium will hold a webcast for media, analysts and institutional investors on Friday, February 10, 2023, at 9.00 am (CET+1). The webcast will be held in

Tina Hultkvist to resign as Volvo Group Chief Financial Officer and member of the Executive Board

Tina Hultkvist has decided to resign from her role as Volvo Group Chief Financial Officer and member of the Executive Board. She has 25 years of experience at Volvo Group and has served as the Volvo Group CFO since March 2022. Jan Ytterberg, previously Volvo Group Chief Financial Officer and member of the Executive Board, and currently in the role of Volvo Group senior advisor, will step in as acting CFO.Tina Hultkvist will leave her role with immediate effect but stands available to the company´s disposal during 2023. The process of recruiting a successor has been initiated. February 3[

Publication of United Bankers Plc’s 2022 Financial Statements Bulletin and invitation to result presentation on 17 February 2023

United Bankers Plc PRESS RELEASE 3 February 2023 at 09:30 EET   Publication of United Bankers Plc’s 2022 Financial Statements Bulletin and invitation to result presentation on 17 February 2023   United Bankers Plc will publish its Financial Statements Bulletin for the period January-December 2022 on Friday 17 February 2023 at approximately 9.00 am. The Financial Statements Bulletin will be available on the Company’s website at www.unitedbankers.fi  after publishing. Patrick Anderson, CEO, will present the result to analysts and

Pihlajalinna Plc publishes Financial Statements Release for January 1–December 31, 2022 on Friday, 17 February, 2023

Pihlajalinna Plc                     Investor News                       3 February 2023 at 9.30 a.m.Pihlajalinna Plc publishes Financial Statements Release for January 1–December 31, 2022 on Friday, 17 February, 2023 Pihlajalinna Plc will publish the Financial Statements Release for the period of January 1–December 31, 2022 on Friday, 17 February, 2023 at approximately 8.00 a.m. The release will be available on the company website . Live webcast for analysts, investors and mediaPihlajalinna will organize

Nordnet: Monthly statistics January

In January, 4,574,600 trades were made in listed financial instruments among Nordnet’s customers, which corresponds to 215,900 trades per day. Number of new customers in January amounted to 14,200, and the total number of customers at the end of January was 1,722,000. Net savings for January was SEK 2.5 billion, the savings capital was SEK 763 billion and lending amounted to SEK 27.6 billion at the end of January. +-----------------+---------+---------+---------+---------+--------+| | January |December | Change  | January |Change  |+-----------------+---------+--------

Gaming Innovation Group completes a deal with Ontario land-based group to power Casino Time

Gaming Innovation Group Inc. (GiG), has today completed its deal with Casino Time Inc, following a Head of Terms agreement announced on 30 November 2022, for the provision of its award winning Platform, Sportsbook and proven OMNI channel solution in Ontario. The deal, which is expected to see the brand go live in H2 this year, marks the fifth operator to be powered by GiG in the region, after the granting of a supplier licence by local regulatory body the AGCO, in July 2022. Canadian owned and operated, Casino Time is a joint venture amongst leading retail operators in Ontario’s

AutoStore: Invitation to presentation of the fourth quarter financial results

(Nedre Vats, 3 February 2023): AutoStore Holdings Ltd (AutoStore: OSE:AUTO) invites investors, analysts and journalists to join the presentation of the fourth quarter 2022 on Thursday 16 February 2023 at 08:00 CET.Reporting day program (CET):   06:00 - Announcement of the fourth quarter 2022 financial results. All material will be made available on www.newsweb.no and www.autostoresystem.com. 08:00 - Presentation at Høyres Hus, Oslo. The presentation will be hosted by Mats Hovland Vikse, CEO, and Bent Skisaker, CFO. The presentation will be followed by a Q&A. The presentation will

Interim Report for the period October – December 2022

The US FDA approved Leqembi™ under the accelerated approval pathway for the treatment of Alzheimer's disease Events during the fourth quarter 2022 · Detailed and positive lecanemab data from the Phase 3 study, Clarity AD, were presented by Eisai at the CTAD Alzheimer Congress. The results were simultaneously published in the New England Journal of Medicine · BioArctic started the two new projects, PD-BT2238, a selective antibody against soluble alpha-synuclein aggregates, and GD-BT6822, an enzyme replacement therapy for Gaucher’s disease. Both projects are combined with the

Orexo submits New Drug Application to FDA for OX124, a high-dose rescue medication for opioid overdose

· OX124 is designed to reverse the effects of the most powerful synthetic opioids, such as fentanyl · Nine out of ten fatal opioid overdoses in the US involve synthetic opioids · If approved, the US launch is expected to be initiated in H1 2024   Uppsala, Sweden – February 3, 2023 – Orexo AB (publ.), (STO:ORX) (OTCQX:ORXOY), today announces the submission of a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for its lead pharmaceutical pipeline asset, OX124, a nasal rescue medication for opioid overdose. OX124, is based on Orexo´s drug delivery platform

BioGaia AB: Year-end report January – December 2022

FOURTH QUARTER 2022 · Net sales amounted to SEK 274.3 million (206.2), an increase of SEK 68.1 million, or 33% (excluding foreign exchange effects, 19%) of which the acquisition of Nutraceutics accounted for an increase of SEK 29.9 million (15%). Organic growth was 5%. · Net sales in the Paediatrics segment amounted to SEK 207.4 million (150.1), an increase of 38% (excluding foreign exchange effects, 24%). · Net sales in the Adult Health segment amounted to SEK 64.7 million (55.2), an increase of 17% (excluding foreign exchange effects, 5%). · Operating expenses amounted to

Year-end report 2022: Stable profit in challenging times

Peab Year-end report, January - December 2022”For 2022 Peab reported a stable profit in challenging times. With our high order backlog and strong financial position, combined with our broad business model, we can handle a multitude of circumstances in different segments and geographies.”, says Jesper Göransson, President and CEO of Peab. Summary according to segment reporting: October – December 2022 · Net sales SEK 17,048 million (17,520) · Operating profit SEK 853 million (1,246). The comparable quarter included repayment of AGS premiums of SEK 179 million · Operating

Zwipe H2 2022 results – Q4 revenue strongest on record

OSLO, NORWAY – 3 February 2023 – Zwipe AS ("Zwipe" or "the company") today announces its results for the second half of 2022. Significant events H2 2022 · The board of Zwipe proposed a fully guaranteed rights issue raising approximately NOK 100 million conditional on the approval of an extraordinary general meeting. · Zwipe announced a significant commercial order for Zwipe Pay totaling $225,000 from a large European Smart Card manufacturer (“SCM”). Zwipe also received another commercial order for Zwipe Pay totaling approximately $80,000 from a leading SCM in the Middle East

Quarterly Report Q4 2022

Record performance in the quarter Fourth quarter · Net sales increased by 28% to a record total of SEK 32,915 M (25,623), with organic growth of 9% (10) and acquired net growth of 5% (–1). Exchange-rates affected sales by 14% (1). · Very strong organic sales growth in Global Technologies, Americas and Entrance Systems, good growth in EMEIA, but a decline in organic sales in Asia Pacific. · Eight acquisitions with combined annual sales of about SEK 1,500 M were signed in the quarter. · ASSA ABLOY has entered into agreements for the sale of Emtek and the Smart Residential

Clinical Laserthermia Systems and Soteria Medical enter strategic partnership

Lund, Sweden – Clinical Laserthermia Systems AB (publ) (CLS) today announces that the company has entered a strategic partnership with Dutch Soteria Medical BV to jointly market and sell the companies combined product portfolios for minimally invasive MRI-guided diagnostic and therapeutic prostate procedures, in markets outside the United States.CLS and Soteria both develop, manufacture and sell image guided products that are used in diagnostic and therapeutic procedures in interventional urology and radiology. The companies products are complimentary of one another with clear benefits to

Nightingale Health combines genetics with its unique blood test results in Livit by Nightingale Health service

Press release, 3 February 2023 at 9:00 a.m. (EET)   Nightingale Health Plc (“Nightingale Health”), a technology company promoting preventative health with its proprietary health risk detection platform, has combined its unique blood test results with genomic data in the latest release of its Livit by Nightingale Health mobile app. The introduction of genetic results into its consumer service follows the company’s announcement in January 2022 of expanding into genetics by acquiring Finnish genetics-testing company Negen Ltd. and launching an international excellence center of genomic data

Wärtsilä Corporation - Manager's transaction: Hietanen, Kari

Wärtsilä Corporation, Managers' transactions, 3.2.2023 at 9:00 EETWärtsilä Oyj Abp - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Kari Hietanen Position: Other senior manager Issuer: Wärtsilä Oyj Abp LEI: 743700G7A9J1PHM3X223 Notification type: INITIAL NOTIFICATION Reference number: 25070/5/4 ____________________________________________ Transaction date: 2023-02-02 Venue: NASDAQ HELSINKI LTD (XHEL) Instrument type: SHARE ISIN: FI0009003727 Nature of transaction: ACQUISITION

Repurchase of Outokumpu’s own shares

Outokumpu OyjStock exchange releaseFebruary 3, 2023, at 9.00 am EETRepurchase of Outokumpu’s own shares On February 2, 2023, Outokumpu has completed repurchases its own shares as follows (ISIN FI0009002422): +-------+----------------+------------------------------------+----------------+|Trading|Number of shares|Weighted average price / share, EUR*|Total cost, EUR*||venue | | | |+-------+----------------+------------------------------------+----------------+|CEUX |57,585 |5.2067

Evondos extends Icelandic deal by two more years

An agreement signed in 2021 to use Evondos medicine-dispensing robots in the home care sector in Iceland’s capital city of Reykjavik has recently been extended by two years. “Both patients and staff have been happy with Evondos’ services, which is very satisfying to hear”, says Evondos Sales Director Markus Mäkelä. As many as 200 robots are expected to be installed in Reykjavik over the next two years as part of a collaboration with Icelandic healthcare and pharmaceuticals retailer Icepharma.Evondos’ robots dispense the correct dose of medicine to patients at the right time. They also

Low-grade inflammation may cause arterial stiffness and preclinical atherosclerosis in otherwise healthy adolescents

Early vascular damage and atherosclerosis in adolescents may be caused by low-grade inflammation, a paper published in the Journal of Applied Physiology concludes. The study was conducted in collaboration between the University of British Columbia in Canada, the University of Bristol in the UK, the University of Exeter in the UK, the University of Illinois in the US, and the University of Eastern Finland. In adults, it is known that low-grade inflammation is a major cause of circulatory, musculoskeletal, gastrointestinal, and nervous system diseases and it can also get worse due to

There are no items matching the current filter
There are no more items matching the current filter
Back to top